Development of Macrocyclic Peptides as Modulators of G-protein Activity

webinar

Thu, 21 Apr 2022, 16:00 CEST (Berlin)

Prof. Dr. Diana Imhof, University of Bonn, Germany

Development of Macrocyclic Peptides as Modulators of G-protein Activity

Heterotrimeric G-proteins are important components of intracellular signal transduction, since G-proteins transmit information from an externally stimulated, membrane-bound G-protein-coupled receptor (GPCR) into the cell interior. The importance of these signaling cascades cannot be denied: More than 30% of the approved drugs address the extracellularly easily accessible GPCRs. Since the Gα subunit directly interacts with both the GPCR and the effectors, Gα plays a crucial role in GPCR signaling. This is reflected in the fact that signaling specificity is achieved through four distinct Gα subfamilies: Gαs, Gαi, Gαq, and Gα12/13, which mediate distinct signaling pathways in the cell. Considering the influence of G-proteins on (patho)physiological processes, tools to modulate the action of Gα proteins are of great interest for current pharmaceutical research. However, the direct targeting of intracellular Gα subunits by chemical agents still is a great challenge, since the activity of the compound must be combined with cell-penetrating properties.

Diana shall present an approach to combine (“wet”) high-throughput techniques with computational approaches to gain a deeper insight into potential binding sites, that can then be addressed for compound design. She will focus on the development of a first series of linear and cyclic peptides, which turned out to possess a GEM (guanine nucleotide exchange modulator)-like activity concerning the modulation of Gai and Gas proteins — this does provide new opportunities for intracellular targeting of GPCR-dependent signaling pathways.
Join Diana and us and learn about her latest GPCR research.

Current news

CCDC Recore Update
category
Software
CCDC ReCore Index now features 49 million possibilities!
May 23, 2022 14:26
In collaboration with the Cambridge Crystallographic Data Centre (CCDC), we updated the prominent ReCore index to feature a colossal number of over 49 million possible 3D fragments for users to search in. ReCore is a part of the SeeSAR’s Inspirator Mode that can be used to screen libraries for geometric...
Read on
category
Software
Hope has arrived: infiniSee 4 — Pandora released!
May 6, 2022 11:51
We are proud to announce version 4 of our Chemical Space navigation platform infiniSee: ‘Pandora’! Named in allegory to finding hope in dark chemical matter, Pandora was developed to discover actives amongst zillions of molecules. With over 40 billion compounds, infiniSee Pandora offers the largest compound collection so far that...
Read on
category
Events
"It's a small world!" — BioSolveIT DrugSpace 2022
April 14, 2022 14:48
Following its huge success with 400+ participants last time around, the new, second virtual BioSolveIT DrugSpace Symposium takes place on May 24th and 25th with the theme “It’s a small world”. Renowned speakers from academia and industry will present recent advances in the field of fragment-based drug discovery (FBDD) and small...
Read on